The features of psychological state, eating behavior, hormonal and adipokine regulation of metabolism in men with subcutaneous and abdominal fat distribution

BACKGROUND: development of obesity and obesity related conditions are directly associated with eating disorders and psychological state. There is increasing focus on the assessment the characteristics of these indicators in men with subcutaneous and central fat distribution, which are associated with various hormonal and adipokine mechanisms that effect on parameters of metabolism and eating behavior.

AIMS: to study the characteristics of the psychologycal state, eating behavior and their relationship with hormonal and adipokine status in men with different fat distribution.

MATERIALS AND METHODS: a single-center, cross-sectional study of 99 men aged 27 to 68 years was performed. 4 groups of men were formed after anthropometric examination. Group 1 (comparison) consisted of men with normal body weight. Group 2 consisted of overweight men, class I obesity and lower subcutaneous fat distribution (SFD). Group 3 consisted of overweight men, men with class I obesity and abdominal fat distribution (AFD); group 4 - men with class II obesity and class III obesity AFD. Eating behavior were determined with DEBQ questionnaire, severity of anxiety-depressive disorders were investigated with the Hospital Anxiety and Depression Scale; body image satisfaction was assessed with body image questionnaire. Serum glucose, triglycerides, insulin, leptin and adiponectin were estimated.

RESULTS: it was shown, that men with AFD had severe metabolic disorders: hyperglycemia, hypertriglyceridemia, hyperinsulinemia and insulin resistance, hyperleptinemia and hypoadiponectinemia, than men with SFD. Men with AFD had an external type of eating behavior, with sever expressed depressive disorders and body image dissatisfaction. Men with SFD had an emotional type of eating behavior and higher body image satisfaction. A comparative analysis between men from 3 and 4 groups with AFD showed that in group 4 in men had higher hyperleptinemia and insulin resistance and there are no differences in severity of eating disorders, anxiety and depression between the groups.

CONCLUSIONS: adipose tissue topography is associated with the psychophysiological, metabolic, hormonal and adipokine characteristics that underlie the development of primary obesity in men.

obesity, subcutaneous fat, abdominal fat, eating behavior, insulin, leptin, adiponectin

1. Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15(5):288-298. DOI:10.1038/s41574-019-0176-8

2. Kelly T, Yang W, Chen C, et al. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond). 2008;32(9):1431-1437. DOI:10.1038/ijo.2008.102

3. Zalesin KC, Franklin BA, Miller WM, et al. Impact of obesity on cardiovascular disease. Endocrinol Metabolism Clin North Am. 2008;37(3):663-684. DOI:10.1016/j.ecl.2008.06.004

4. Garvey WT. Clinical Definition of Overweight and Obesity. In: Gonzalez-Campoy J, Hurley D, Garvey WT, editors. Bariatric Endocrinology. Springer: Cham; 2019. p. 121-143. DOI:10.1007/978-3-319-95655-8_7

5. Волкова Г.Е., Романцова Т.И., Вознесенская Т.Г., Роик О.В. Пищевое поведение у пациентов с ожирением // Ожирение и метаболизм. — 2007. — Т. 4. — № 2. – С. 17-21. [Volkova GE, Romantsova TI, Voznesenskaya TG, Roik OV. Pishchevoe povedenie u patsientov s ozhireniem. Obesity and metabolism. 2007;4(2):17-21. (In Russ.)] DOI:10.14341/2071-8713-5158

6. Исаченкова О.А. Пищевое поведение как важный фактор развития ожирения и коморбидных с ним заболеваний // Ожирение и метаболизм. — 2015. — Т. 12. — № 4. — С. 14-17. [Isachenkova OA. Eating behavior as an important factor in the development of obesity and comorbid diseases. Obesity and metabolism. 2015;12(4):14-17. (In Russ.)] DOI:10.14341/omet2015414-17

7. Lee MJ, Wu Y, Fried SK. Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications. Mol Aspects Med. 2013;34(1):1-11. DOI:10.1016/j.mam.2012.10.001

8. Feijoo-Bandin S, Rodriguez-Penas D, Garcia-Rua V, et al. Adipokines at the cardiovascular system: role in health and disease. SM J Endocrinol Metab. 2016;2(1):1009-1016. DOI:10.2478/immun-2013-0004

9. Шляхто Е.В., Недогода С.В., Конради А.О., и др. Концепция новых национальных клинических рекомендаций по ожирению // Российский кардиологический журнал. — 2016. — Т. 21. — № 4. — С. 7-13. [Shlyakhto EV, Nedogoda SV, Konradi AO, et al. The concept of novel national clinical guidelines on obesity. Russian journal of cardiology. 2016;21(4):7-13. (In Russ.)] DOI:10.15829/1560-4071-2016-4-7-13

10. Dobson R, Burgess MI, Sprung VS, et al. Metabolically healthy and unhealthy obesity: differential effects on myocardial function according to metabolic syndrome, rather than obesity. Int J Obes (Lond). 2016;40(1):153-161. DOI:10.1038/ijo.2015.151

11. Бородкина Д.А., Груздева О.В., Квиткова Л.В. Барабаш О.Л. Распределение жировых отложений: разгадка кажущегося парадокса ожирения в кардиологии? // Ожирение и метаболизм. — 2017. — Т. 14. — № 2. — С. 3-8. [Borodkina DA, Gruzdeva OV, Kvitkova LV, Barbarash OL. Body fat distribution: the answer to the apparent paradox of obesity in cardiology? Obesity and metabolism. 2017;14(2):3-8. (In Russ.)] DOI:10.14341/omet201723-8

12. Freedland ES. Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review. Nutr Metab (Lond). 2004;1:12. DOI:10.1186/1743-7075-1-12

13. Аметов А.С., Абдулкадирова Ф.Р., Покровская Р.А., и др. Ожирение: роль лептина // Лечение и профилактика. — 2014. — № 2. — С. 86-91. [Ametov AS, Abdulkadirova FR, Pokrovskaya RA., et al. The obesity: the role of leptin. Disease treatment and prevention. 2014;(2):86-91. (In Russ.)]

14. Han TS, Lean MEJ. A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. JRSM Cardiovasc Dis. 2016;5:2048004016633371. DOI:10.1177/2048004016633371

15. Grundy SM. Metabolic syndrome update. Trends Cardiovasc Med. 2016;26(4):364-373. DOI:10.1016/j.tcm.2015.10.004

16. Heitmann BL, Frederiksen P. Thigh circumference and risk of heart disease and premature death: prospective cohort study. BMJ. 2009;339:b3292. DOI:10.1136/bmj.b3292

17. van Strein T, Frijtere JER, Bergere GPA, Defares PB. The Dutch eating behavior questionnaire (DEBQ) for assessment of restrained emotional and external eating behavior. Int J Eat Disord. 1986;5(2):295-315. DOI:10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T

18. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression scale. Acta Psychiatr Scand. 1983;67(6):361-370. DOI:10.1111/j.1600-0447.1983.tb09716.x

19. Малкина-Пых И.Г. Терапия пищевого поведения. Справочник практического психолога. — М.: Эксмо; 2007. [Malkina-Pykh IG. Terapiya pishchevogo povedeniya. Spravochnik prakticheskogo psikhologa. Moscow: Eksmo, 2007. (In Russ.)]

20. Пинхасов Б.Б., Селятицкая В.Г., Карапетян А.Р., Лутов Ю.П. Ассоциация возрастного ожирения с метаболическим синдромом у мужчин // Успехи геронтологии. — 2016. — Т. 29. — № 1. — С. 86-92. [Pinkhasov BB, Selyatitskaya VG, Karapetyan AR, Lutov YP. Association of aging-related obesity and metabolic syndrome in men. Adv Gerontol. 2016;6(3):224-230. (In Russ.)] DOI:10.1134/S2079057016030085

21. Moehlecke M, Canani LH, Silva LOJE, et al. Determinants of body weight regulation in humans. Arch Endocrinol Metab. 2016;60(2):152-162. DOI:10.1590/2359-3997000000129

22. Cui H, López M, Rahmouni K. The cellular and molecular bases of leptin and ghrelin resistance in obesity. Nat Rev Endocrinol. 2017;13(6):338-351. DOI:10.1038/nrendo.2016.222

23. Larsen MA, Isaksen VT, Moen OS, et al. Leptin to adiponectin ratio – a surrogate biomarker for early detection of metabolic disturbances in obesity. Nutr Metab Cardiovasc Dis. 2018;28(11):1114-1121. DOI:10.1016/j.numecd.2018.06.020

24. Nisar MK, Afaq E, Afaq H, et al. Leptin to Adiponectin ratio as Atherogenic Index in Ischemic Heart Disease Patients. Journal of Islamabad Medical & Dental College. 2018;7(4):285-290. DOI:10.35787/jimdc.v7i4.265

25. Wang T, Ma X, Peng D, et al. Effects of obesity related genetic variations on visceral and subcutaneous fat distribution in a Chinese population. Sci Rep. 2016;6:20691. DOI:10.1038/srep20691

26. Brune JE, Kern M, Kunath A, et al. Fat depot-specific expression of HOXC9 and HOXC10 may contribute to adverse fat distribution and related metabolic traits. Obesity (Silver Spring). 2016;24(1):51-59. DOI:10.1002/oby.21317

27. Pinkhasov BB, Selyatitskaya VG, Karapetyan AR, Astrakhantseva EL. Metabolic syndrome in men and women with upper or lower types of body fat distribution. Health. 2012;4(12A):1381-1389. DOI:10.4236/health.2012.412A200

28. Кодочигова А.И., Мартынова А.Г., Киричук В.Ф. Психологические особенности личности в зависимости от типа распределения жировой ткани у клинически здоровых лиц // Кардиоваскулярная терапия и профилактика. — 2005. — Т. 4. — № 2. — С. 84-89. [Kodochigova AI, Martynova AG, Kirichuk VF. Psychological personality traits in healthy people with various types of fat tissue distribution. Cardiovascular therapy and prevention. 2005;4(2):84-89. (In Russ.)]

29. Wurtman RJ, Wurtman JJ. Brain serotonin, carbohydrate-craving, obesity and depression. Obes Res. 1995;3 Suppl 4:477S-480S. DOI:10.1002/j.1550-8528.1995.tb00215.x

30. Соболева Н.П., Руднев С.Г., Николаев Д.В., и др. Биоимпедансный скрининг населения России в центрах здоровья: распространенность избыточной массы тела и ожирения // Российский медицинский журнал. — 2014. — Т. 20. — № 4. — С. 4-13. [Soboleva NP, Rudnev SG, Nikolayev DV, et al. The bio-impedance screening of population in health centers: prevalence of surplus body mass and obesity. Russian medical journal. 2014;20(4):4-13. (In Russ.)]

31. Герасимов А. Н. Медицинская статистика: учебное пособие. М. – Изд. Медицинское информационное агентство. – 2007. [Gerasimov AN. Medical statistics: study guide. M. Publ. Medical Information Agency. (In Russ.)]